Beneficial effects of sunitinib on tumor microenvironment and immunotherapy targeting death receptor5.
Tsukita Y, Okazaki T, Ebihara S, Komatsu R, Nihei M, Kobayashi M, Hirano T, Sugiura H, Tamada T, Tanaka N, Sato Y, Yagita H, Ichinose M.
Tsukita Y, et al. Among authors: yagita h.
Oncoimmunology. 2018 Nov 13;8(2):e1543526. doi: 10.1080/2162402X.2018.1543526. eCollection 2019.
Oncoimmunology. 2018.
PMID: 30713805
Free PMC article.